Abstract
Aged women with osteoporosis were followed for 6 months with or without ipriflavone (IP) 600 mg/day, and lumbar bone mineral density (BMD) and bone mineral content (BMC) were evaluated by dual-photon absorptiometry. Although a significant reduction of lumbar BMD was observed in the control group at the end of the experiment, the group treated with IP showed insignificant change. The frequency of deterioration was lower in the IP group compared to the control group. Additionally, the IP effect was more apparent in patients with lower calcitonin and higher bone gla-protein (BGP) levels. These results suggest that IP effectively maintains BMD and BMC of lumbar bone among aged women with osteoporosis, and its activity may be enhanced in patients with low calcitonin and high BGP levels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Suda A. Effect of parathyroid hormone on parietal bones of rats and effect of ipriflavone. J Bone Miner Metab 1987;5:37–42
Hashizume K, Yamauchi K, Nishii H, et al. Effect of ipriflavone on diabetic osteoporosis: Enhancement of calcitonin secretion by ipriflavone. Shinyaku to Rinshou 1990;39:75–83
Agnusdei D, Camporeale A, Gennari C, et al. Effects of ipriflavone on bone mass and bone remodeling in patients with established postmenopausal osteoporosis. Curr Therap Res 1992;51:82–91
Agnusdei D, Adami S, Gennari C, et al. Effect of ipriflavone on bone mass and metabolism in postmenopausal osteoporosis. Abstract of satellite symposium of 11th International Conference on Calcium-Regulating Hormones, 1992
Tsuda M, Kitazaki T, Ito T, Fujita T. The effect of ipriflavone (TC-80) on bone resorption in tissue culture. J Bone Miner Res 1986;1:207
Bonucci E, Ballanti P, Bufalino L, et al. Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of rats. Calcif Tissue Int 1992;50:314–319
Benvenuti S, Tanini A, Brandi ML, et al. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. J Bone Miner Res 1991;6:987–996
Ohta H, Ikeda T, Nozawa S, et al. Influence on bone metabolism and ameliorating effect of ipriflavone. Proceedings of Progress of Drugs on Osteoporosis. Medical Tribune pp 11–12, 1992
Author information
Authors and Affiliations
About this article
Cite this article
Miki, T., Aratani, H., Yoshida, H. et al. Effect of ipriflavone on bone mineral density of lumbar spine of aged women. J Bone Miner Metab 11 (Suppl 1), S26–S29 (1993). https://doi.org/10.1007/BF02378747
Issue Date:
DOI: https://doi.org/10.1007/BF02378747